2010 CEND Symposium - Mechanisms of Drug Therapy and Resistance in HIV and TB - Part 1 Julie Gerberding, Merck Vaccines - "Global Health: Reducing Threats & Raising Resilience" Welcome & Opening Remarks: Dan Portnoy, CEND Associate Director globalhealth.berkeley.edu/cend/ Funding for this conference was made possible in part by Grant 1R24TW008822 from the NIH Fogarty International Center. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the NIH; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Be the first to comment